South Korea
DX&VX Advances Universal Coronavirus Vaccine to Address Breakthrough Infections and Variants
The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of&...
January 09, 2025 | News
Samsung Biologics and LigaChem Biosciences Partner to Advance ADC Therapies with New Dedicated Facility
Samsung Biologics to offer ADC services at new dedicated facility Extended collaboration reflects successful partnership and expertise Samsung Biolog...
January 09, 2025 | News
Sanofi and SK Bioscience Forge Expanded Alliance to Combat Pneumococcal Disease with Next-Gen Vaccines
Pneumococcal disease remains a major global health challenge despite the availability of current vaccines This 21-valent pneumococcal conjugate vaccine ...
December 23, 2024 | News
Illumina Joins Forces with Macrogen Consortium to Drive Korea's National Bio Big Data Project
Illumina is proud to be selected as sequencing technology partner to the Macrogen Consortium. Macrogen a global healthcare company that specializes in pre...
December 23, 2024 | News
South Korea invests in Generate Biomedicines through Samsung to drive global biopharma innovation.
Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics disc...
December 18, 2024 | News
SK Biopharmaceuticals and ProEn Therapeutics to Develop Two Radiopharmaceutical Candidates by 2027 Using ArtBody™ Platform
SK Biopharmaceuticals, ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027, via ArtBody™, a bivalent binder ...
December 17, 2024 | News
James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
LOTTE BIOLOGICS is pleased to announce that James Park will assume the role of Chief Executive Officer, effective December 11, 2024. Mr. Park brings with ...
December 16, 2024 | News
CHMP Endorses Celltrion’s Biosimilars Eydenzelt Stoboclo Osenvelt and Avtozma for Expanded Access to Biologic Treatments
The Committee for Medicinal Products for Human Use (CHMP) adopts positive opinions for Celltrion’s three biosimilar candidates – Eydenz...
December 16, 2024 | News
HiRO Partners with South Korea’s CHA Bundang Medical Center to Advance Global Clinical Trials
Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) providing cross-border clinical trial sol...
December 16, 2024 | News
GNT Pharma Announces Promising Nelonemdaz Results, Initiates Global Phase 3 Stroke Trials
** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Mult...
December 12, 2024 | News
SNUBH, CurePSP, and GemVax Unite to Establish Korea’s First International PSP Research and Treatment Center
MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment Center Tackling Global Challenges in an Aging Er...
December 10, 2024 | News
Samsung Biologics Hosts Second Supplier ESG Day, Rallying Global Partners for Sustainable Value Chains
Samsung Biologics , a global contract development and manufacturing organization (CDMO), hosted its second Supplier ESG Day to share insights on sustainabl...
December 03, 2024 | News
Lunit Partners with Mexico's Salud Digna to Advance AI-Driven Cancer Diagnostics Across Latin America
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic partnership with&nbs...
November 28, 2024 | News
South Korea’s Newbase Launches ‘Medicrew,’ Transforming VR-Based Medical Education Globally
Newbase, a leader in metaverse-based medical education platforms, announced on the 28th the launch of its new product, 'Medicrew', a platform designed to p...
November 28, 2024 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
